Replies to post #76166 on Innovation Pharmaceuticals Inc (IPIX)

[TheDane]

I just read the portion of the S-3 regarding this. It's probably not a good idea to read too much into the change in language...

...but it sure is tempting. :-)

Go CTIX!

[loanranger]

"Its been all B lately and now no mention of antibiotics???"

Are you saying that you don't think that the following includes a reference to Brilacidin and antibiotics?
"We are a clinical stage developmental biotechnology pharmaceutical company focused on discovering small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism and inflammatory disease."

Half a dozen sentences later:
"On October 23, 2014, we announced positive top-line data from our Phase 2b ABSSSI trial with our lead antibiotic compound, Brilacidin."

And a little further on:
"We are further developing Brilacidin for the treatment of diabetic foot ulcer infections and other indications such as, ophthalmic and otitic infections. Also in development are novel compounds for Gram negative and fungal infections."


The scientists can tell me whether one would be correct if they were to say:
"All inflammations are not signs of infection, but all infections involve some sign of inflammation."


Wouldn't oral mucositis and ABSSSI be considered inflammatory diseases?